These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3564859)

  • 1. Tumor distribution classification system for multiple myeloma: clinical features and prognosis.
    Sezaki T; Izumi K; Hoshijima T; Adachi T; Takahashi I; Kimura I
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1784-91. PubMed ID: 3564859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic classification and staging of multiple myeloma.
    Bartl R
    Hematol Oncol; 1988; 6(2):107-13. PubMed ID: 3391529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone lesions in multiple myeloma: variation and value of radiologic classification in prognosis].
    Elloumi M; Bellaaj H; Ayedi K; Zitoun I; Mseddi S; Frikha M; Kechaou MS; Souissi T
    Tunis Med; 2002 Sep; 80(9):519-23. PubMed ID: 12632764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
    Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
    Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow imaging in plasma cell dyscrasias: review of 130 cases.
    Feggi LM; Scutellari PN; Prandini N; Orzincolo C; Spanedda R
    J Nucl Biol Med (1991); 1992; 36(4):303-8. PubMed ID: 1296769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and quantitative MRI assessment of bone marrow in multiple myeloma and chronic lymphocytic leukemia: clinical and prognostic value.
    Lecouvet F
    J Belge Radiol; 1998 Dec; 81(6):301. PubMed ID: 10063768
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed tomography in diagnosis and management of multiple myeloma and its variants.
    Kyle RA; Schreiman JS; McLeod RA; Beabout JW
    Arch Intern Med; 1985 Aug; 145(8):1451-2. PubMed ID: 4026477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemocytological classification, clinical staging and polychemotherapy of multiple myeloma].
    István L; Karl W; Michael H; Günter A; Kelényi G; Várbíró M; Dieter R
    Orv Hetil; 1983 Feb; 124(6):313-9. PubMed ID: 6835675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.
    Van de Berg BC; Lecouvet FE; Michaux L; Labaisse M; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
    Radiology; 1996 Oct; 201(1):243-6. PubMed ID: 8816551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
    Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
    Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
    Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
    Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of bone marrow biopsy in the multiple myeloma.
    Bartl R; Burkhardt R; Gierster P; Sandel P; Fateh-Moghadam A
    Bibl Haematol; 1978; 45():81-6. PubMed ID: 747638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.